Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities

Ads

You May Also Like

Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update

Recent Minimally Dilutive Financings Substantially Strengthen Balance Sheet and Provide Runway to Significant Clinical ...

HalioDx : Immunoscore(r) Colon test available

Immunoscore® has confirmed its potential to become a major component of the colon cancer ...

BeiGene Reports Third Quarter 2018 Financial Results

CAMBRIDGE, Mass. and BEIJING, China, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...